LimiTT: link miRNAs to targets

Julia Bayer1, Carsten Kuenne1, Jens Preussner1

  • 1Group of Bioinformatics, Max Planck Institute for Heart and Lung Research, Ludwigstrasse 43, D-61231, Bad Nauheim, Germany.

BMC Bioinformatics
|May 13, 2016
PubMed
Abstract

Insights

LimiTT integrates validated miRNA target interaction data from multiple databases for 26 species. This tool aids in identifying species-specific and non-specific interactions, improving research in both standard and niche model organisms.

Area of Science:

  • Molecular Biology
  • Bioinformatics

Background:

  • MicroRNAs (miRNAs) regulate gene expression post-transcriptionally by binding to target messenger RNAs (mRNAs).
  • Investigating miRNA-target interactions (MTIs) is crucial but challenging due to in silico prediction inaccuracies and data limitations, especially for niche model organisms.
  • Existing databases for experimentally validated MTIs have restricted search functionalities and inconsistent identifier usage.

Purpose of the Study:

  • To develop a comprehensive pipeline, LimiTT, for integrating and analyzing experimentally validated miRNA-target interactions (MTIs).
  • To overcome limitations of existing databases by enabling species-specific and non-specific MTI identification with dynamic quality criteria.
  • To facilitate MTI research across diverse model organisms, including niche ones, by mapping homologous target identifiers.

Main Methods:

  • Integration of four existing databases containing experimentally validated MTIs.
  • Development of a pipeline (LimiTT) for data aggregation and analysis.
  • Implementation of dynamic quality criteria for MTI identification and enrichment analysis.
  • Mapping to homologous target identifiers to enable cross-species MTI discovery.

Main Results:

  • LimiTT successfully integrates MTI data from four databases, covering 26 species.
  • The pipeline allows for the identification and enrichment analysis of MTIs, with or without species specificity.
  • Multiple tabular and graphical outputs are generated for detailed assessment of MTI data.
  • The system provides high granularity in linking miRNAs and putative targets.

Conclusions:

  • The freely available web-based pipeline, LimiTT, is optimized for determining species-specific and non-specific MTIs.
  • LimiTT enhances MTI discovery for both standard and niche model organisms through integrated mapping to homologous target identifiers.
  • The tool offers a robust solution for detailed MTI assessment and analysis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K